FDA Approves Drug to Cut Cholesterol

Source: PharmaManufacturing.com

May 06, 2013

The New York Times

The Food and Drug Administration approved a combination drug developed by Merck that lowers a patient’s cholesterol but has not been shown to reduce the risk of cardiovascular disease or death, the company said.

The drug pairs Merck’s Zetia, which lowers low-density lipoprotein (LDL or “bad cholesterol”) with the generic version of Lipitor, the best-selling statin made by Pfizer that lost its patent protection in 2011. Read the full story.
Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments